Synapse - GDMT, Medicine

Results (1898)

Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study

Meeting Abstract

Vergote, I. B.; Monk, B. J.; O'Cearbhaill, R. E.; Westermann, A. M.; Banerjee, S.; Collins, D. C.; Mirza, M. R.; O'Malley, D.; Gennigens, C.; Pignata, S.; more...
Annals of Oncology (2021)

Fulltext@MSK | Save

Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician's choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-775)

Meeting Abstract

Colombo, N.; Lorusso, D.; Casado Herráez, A.; Santin, A. D.; Colomba, E.; Miller, D. S.; Fujiwara, K.; Pignata, S.; Floquet, A.; Monk, B. J.; more...
Annals of Oncology (2021)

Fulltext@MSK | Save

Association between biomarkers and clinical outcomes of lenvatinib (L) + pembrolizumab (P) in advanced endometrial cancer (EC): Results from KEYNOTE-146/study 111

Meeting Abstract

Makker, V.; Taylor, M. H.; Aghajanian, C.; Cohn, A. L.; Brose, M. S.; DiSimone, C.; Cao, A.; Suttner, L.; Loboda, A.; Cristescu, R.; more...
Annals of Oncology (2021)

Fulltext@MSK | Save

Relacorilant, a selective glucocorticoid receptor modulator, in combination with nab-paclitaxel improves progression-free survival in patients with recurrent platinum-resistant ovarian cancer: A 3-arm, randomized, open-label, phase II study

Meeting Abstract

Colombo, N.; Nguyen, D. D.; Fleming, G. F.; Grisham, R. N.; Lorusso, D.; Van Gorp, T.; Oaknin, A.; Pashova, H. I.; Grauer, A.
Annals of Oncology (2021)

Fulltext@MSK | Save

Therapeutic implications of germline testing in patients with advanced cancers

Journal Article

Stadler, Z. K.; Maio, A.; Chakravarty, D.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; Tkachuk, K.; Fong, C. J.; Nguyen, B.; Erakky, A.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: An MSK Team Ovary phase II study

Journal Article

Zivanovic, O.; Chi, D. S.; Zhou, Q.; Iasonos, A.; Konner, J. A.; Makker, V.; Grisham, R. N.; Brown, A. K.; Nerenstone, S.; Diaz, J. P.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Diagnosis and management of an endometrial cancer patient with Cowden syndrome

Journal Article

Manning-Geist, B. L.; Gatius, S.; Liu, Y.; Gil, M.; Da Cruz Paula, A.; Tuset, N.; Abu-Rustum, N. R.; Aghajanian, C.; Weigelt, B.; Matias-Guiu, X.
Gynecologic Oncology (2021)

Fulltext@MSK | Save

Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy

Journal Article

Basaran, D.; Boerner, T.; Suhner, J.; Sassine, D.; Liu, Y.; Grisham, R. N.; Tew, W. P.; Gardner, G. J.; Zivanovic, O.; Sonoda, Y.; more...
Gynecologic Oncology (2021)

Fulltext@MSK | Save

Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial

Journal Article

Colombo, N.; Moore, K.; Scambia, G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; Gourley, C.; more...
Gynecologic Oncology (2021)

Fulltext@MSK | Save

Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety

Journal Article

Oaknin, A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; Leary, A.; more...
Cancer Medicine (2021)

Fulltext@MSK | Save